J.B. Chemicals & Pharmaceuticals (BOM:506943) LT-Debt-to-Total-Asset : 0.01 (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is J.B. Chemicals & Pharmaceuticals LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. J.B. Chemicals & Pharmaceuticals's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.01.

J.B. Chemicals & Pharmaceuticals's long-term debt to total assets ratio declined from Mar. 2023 (0.11) to Mar. 2024 (0.01). It may suggest that J.B. Chemicals & Pharmaceuticals is progressively becoming less dependent on debt to grow their business.

J.B. Chemicals & Pharmaceuticals LT-Debt-to-Total-Asset Historical Data

The historical data trend for J.B. Chemicals & Pharmaceuticals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.B. Chemicals & Pharmaceuticals LT-Debt-to-Total-Asset Chart

J.B. Chemicals & Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.11

0.01

J.B. Chemicals & Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.11	-	0.08	-	0.01

J.B. Chemicals & Pharmaceuticals LT-Debt-to-Total-Asset Calculation

J.B. Chemicals & Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	332.8	/	39941.3
	=	0.01

J.B. Chemicals & Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	332.8	/	39941.3
	=	0.01

J.B. Chemicals & Pharmaceuticals (BOM:506943) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

J.B. Chemicals & Pharmaceuticals LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of J.B. Chemicals & Pharmaceuticals's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

J.B. Chemicals & Pharmaceuticals (BOM:506943) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

JBCHEPHARM:India

Address

Appa Saheb Marathe Marg, Cnergy IT Park, Unit A2, 3rd floor, Unit A, 8th floor, Prabhadevi, Mumbai, MH, IND, 400 025

Website

https://www.jbpharma.com

J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.

J.B. Chemicals & Pharmaceuticals (BOM:506943) Headlines

No Headlines